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Abstract: Objective: We investigated the prevalence of bronchial asthma in patients with Tako-Tsubo Syndrome (TTS).  
Design: This retrospective case-series study was conducted in a primary care hospital in Zurich, Switzerland. Data of all 
patients with newly diagnosed TTS (2002 - 2012) were assessed electronically by the use of ICD-10. Asthma prevalence 
was compared to published epidemiologic data.  
Setting: Bronchial asthma is characterized by airway inflammation and, during attack, release of endogenous 
catecholamines. Sympathomimetic drugs are the mainstay of treatment for asthma patients. Likewise, catecholamine 
mediated diffuse microvascular myocardial dysfunction seems to be of critical importance for the development of TTS.  
Results: 20 cases of TTS were identified. 90% were female, showed a median age of 70±13y [25y - 90y], an apical and/or 
midventricular ballooning pattern with preserved basal function and a median initial LVEF of 34±9% [25% - 55%]. 65% 
of patients underwent coronary angiography to rule out significant coronary artery disease. Hypertension was present in 
45% of patients, 35% were smokers, none was suffering from diabetes. Prevalence of asthma in patients with TTS was 
significantly higher compared to the normal population (25% vs. 7%, p=0.012). In 30% of the TTS patients an iatrogenic 
cause for development of TTS was identified.  
Conclusion: Prevalence of asthma was significantly higher in patients with TTS compared to epidemiologic data from an 
age-matched population. Phenotypes of patients developing obstructive ventilatory disease and TTS might share common 
pathogenic mechanisms beyond the use of bronchodilatators. In addition, we identified other iatrogenic etiologies in 
patients with TTS.  
Keywords: Bronchial asthma, sympathomimetic drugs, Tako-Tsubo-Syndrome. 
INTRODUCTION 
 Tako-Tsubo-Syndrome (TTS) was reported 1991 by Dote 
et al. [1] and describes the resemblance of the left ventricle 
during systole to Japanese octopus fishing pots. Patients with 
TTS present with chest pain or sudden dyspnoea, 
electrocardiographic changes and elevated cardiac enzymes 
mimicking myocardial infarction in absence of significant 
coronary stenosis. Transthoracic echocardiogram shows 
transient akinesis in the apical and/or middle ventricular 
segments (apical ballooning) and hyperkinesis in the basal 
segments of the left ventricle impairing ventricular ejection 
fraction [2] These wall-motion abnormalities usually 
completely resolve within days or weeks [3]. Incidence of 
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TTS in patients presenting with acute coronary syndromes is 
estimated to be around 2% [4, 5] The onset of TTS is often 
preceded by emotional or physical stress and the condition 
is, as such, also known as “broken heart syndrome” or stress-
induced cardiomyopathy. However, in 30% of cases the 
trigger factor remains unclear [3]. Of interest, in patients 
with TTS, plasma catecholamine levels have found to be 
several times higher as compared to patients with myocardial 
infarction and remained markedly elevated over a period of a 
week [6]. The elevated levels of catecholamines have been 
associated with diffuse microvascular myocardial 
dysfunction and subsequent ischemia as a possible 
mechanism, whereas the increased adrenergic receptor 
density in cardiac apical segments might explain the unequal 
affection of the myocardium and, thus, the typical shape of 
affected hearts in transthoracic echocardiogram or 
ventriculography [7]. 
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 Another disease in which sympathomimetic reactions 
might play an important role both in pathogenesis and 
treatment is bronchial asthma. Bronchial asthma is a 
common disease with an increasing prevalence affecting 
about 7% of the Swiss adult population [8]. The airway 
inflammation observed in bronchial asthma is, at least in 
part, triggered by cytokines such as IL-4, -5, and -13 [9], 
driving the eosinophilic response. The inflammatory IL-6 
that appears to correlate with levels of IL-13 has been 
reported to be another trigger factor [10, 11]. Moreover, 
during an acute asthma attack, endogenous catecholamines 
are released [12]. 
 These mediators might also be of critical importance for 
the development of TTS and, due to the major role of 
sympathomimetic drugs in the treatment of bronchial asthma 
as well as the release of endogenous catecholamines in 
exacerbations and acute asthma attacks, we assumed a higher 
prevalence of bronchial asthma in patients with TTS. 
METHODS 
 To address this hypothesis, a retrospective case-series 
study was conducted in a primary care hospital in Zurich, 
Switzerland. Data of all patients with newly diagnosed TTS 
were assessed from the hospital electronic patients database 
by use of the ICD-10 code. Data for several codes (e.g. 
I51.8, I42.8) were investigated. Upon identifying the cases of 
TTS, analysis for trigger factors, cardiovascular risk factors, 
left ventricular ejection fraction (LVEF) at time of initial 
diagnosis and at follow-up, results of coronary angiography 
and comorbidities was conducted. Patients from a period of 
10 years (2002 – 2012) were included. Asthma prevalence in 
patients with TTS was compared to epidemiologic data for 
asthma in Switzerland. Statistical analysis was performed 
with GraphPad using non-parametric tests.  
RESULTS 
 Over a period of 10 years, 20 cases of TTS were 
identified (details provided in Table 1). Of these cases, 90% 
were female, showed a median age of 70±13y [25y – 90y], 
an apical and/or midventricular ballooning pattern with 
preserved basal function and a median initial left ventricular 
ejection fraction of 34±9% [25% - 55%]. 65% of patients 
underwent coronary angiography to rule out significant 
atherothrombotic coronary artery disease. Hypertension was 
present in 45% of patients, 35% were smokers, none was 
suffering from diabetes. 5 of the TTS patients had been 
diagnosed with bronchial asthma. 3 of these had been treated 
with bronchodilatators only, two of which with short acting 
relievers. 2 patients additionally used inhaled corticosteroids. 
At time of hospitalization, none of the patients was under 
systemic corticosteroid therapy. In 2 patients, both without 
inhaled corticosteroids, the asthma was uncontrolled and 
symptomatic asthma was the reason for hospitalization. 
According to the patient files, the asthma was controlled in 
the 3 other patients. When assessed with Fisher’s exact test, 
the prevalence of asthma in patients with TTS was 
significantly higher compared to the normal population (25% 
vs. 7%, p=0.012). The number detected in our small 
inpatient cohort might even be underestimated since one 
patient was hospitalized with acute exacerbated chronic 
obstructive pulmonary disease. However, this patient was a 
lifelong nonsmoker and it is probable that the irreversible 
obstruction was due to airway remodeling from chronic 
asthma. Because no formal diagnosis of asthma has been 
Table 1. Clinical characteristics of 20 inpatients with newly diagnosed stress induced cardiomyopathy (TTS). 
 
 
Retrospective Analysis in a Primary Care Hospital The Open Cardiovascular Medicine Journal, 2015, Volume 9    3 
mentioned in the electronic data file, this patient was not 
counted as having asthma. 
 As an additional finding independent of the diagnosis of 
asthma, in 30% of the TTS patients an iatrogenic cause for 
development of TTS was identified (treatment with 
sympathomimetic drugs in 20%; surgical procedures in 
10%).  
DISCUSSION 
 We describe here a significantly higher prevalence of 
asthma in patients with TTS compared to the normal 
population in Switzerland. These retrospectively collected, 
descriptive data are limited by the lack of formal controls 
and the low number of cases identified, the latter of which is 
mainly due to an allocation bias since patients presenting 
with acute chest pain and electrocardiographic changes 
compatible with ST-elevation myocardial infarction are not 
admitted to our clinic. Furthermore, only two thirds of 
patients underwent coronary angiography to rule out 
significant atherosclerosis which is warranted for the 
diagnosis of TTS according to the Mayo Clinic criteria for 
apical ballooning syndromem [2]. However, since all 
patients without invasive diagnostic assessment showed 
typical echocardiographic features of TTS (i.e. transient 
hypokinesis, akinesis or dyskinesis of the left ventricular mid 
segments) and complete normalization of LVEF within the 
follow-up, ischemic heart disease is an unlikely cause of the 
observed features in this cohort of patients. Hence our results 
might be representative for other primary care hospitals that 
are lacking coronary catheterization facilities. Our data 
suggest that comorbidities (i.e. bronchial asthma) and 
iatrogenic causes (i.e. medication) might be underestimated 
in the inpatient setting. While complete understanding of 
pathogenesis of TTS is still lacking, recent data suggest 
catecholamine mediated diffuse microvascular myocardial 
dysfunction as a possible mechanism. Of interest, in patients 
with TTS, plasma levels of catecholamines were found to be 
significantly increased compared to patients with myocardial 
infarction and these levels remained markedly elevated over 
several days [6]. In this retrospective study we have not 
analyzed levels of catecholamines or inflammatory 
cytokines. But our data suggest a potential interplay of 
asthma and TTS probably triggered by the use of 
sympathomimetic drugs and elevated levels of endogenous 
catecholamines. In addition, experimental data make it very 
likely that, next to catecholamines and betamimetic drugs, 
other factors could promote a final common pathway in both 
entities (summarized in Fig. 1). For example, in climacteric 
women suffering from psychological stress, the serum levels 
of several cytokines have been found elevated, in particular 
IL-6 [13]. While postmenopausal women are prone to 
develop TTS, elevated levels of IL-6 interestingly were 
found to be increased predominantly in female asthmatic 
patients [11]. IL-6 is one of the most important triggers of 
the acute phase response and was shown to result in aberrant 
expression of microRNAs [14, 15], which might also be 
involved in the pathogenesis of cardiomyopathies. Finally, a 
sustained hypereosinophilic response might be the result of 
eosinophilic granulomatosis with polyangiitis, which 
commonly presents with uncontrolled bronchial asthma. 
Churg Strauss vasculitis could mimic TTS, in particular with 
myocardial involvement. In our patients, however, we had no 
evidence for an “asthma-plus” syndrome such as Churg 
strauss vasculitis.  
CONCLUSION 
 In conclusion, since we are not aware of any studies 
addressing the prevalence of bronchial asthma in inpatients 
with TTS, we show here first evidence of an association 
between these two entities. Phenotypes of patients 
developing obstructive ventilatory disease (in particular 
bronchial asthma) and TTS might share common pathogenic 
mechanisms beyond the use of bronchodilatators. In 
addition, we identified other iatrogenic – and thus 
preventable – etiologies in one-third of patients with TTS. 
The use of synthetic catecholamines, which, of note, is of 
controversial benefit in acute asthma [16], thus should be 
 
Fig. (1). Proposed models of the interplay in the pathogenesis of 
bronchial asthma and Takotsubo syndrome. Psychological stress, 
which might also aggravate bronchial asthma [17], is the main 
known trigger factor for the development of TTS. The most 
important downstream mediators of psychological stress are 
sympathomimetics (i.e. endogenous or iatrogenic catecholamines) 
that act through betaadrenergic receptors. Psychological stress also 
increases the level of serum cytokines, in particular of IL-6, which 
is found elevated in female asthmatic patients and triggers the acute 
phase response. The involvement of microRNAs is hypothetical. 
The hypereosinophilic response in Churg-Strauss vasculitis might 
offer a differential diagnosis when bronchial asthma and heart 
failure present concomitantly. 
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handled with caution, in particular in postmenopausal female 
patients that are at high risk to develop TTS. 
ABBREVIATION 
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